Skip to content

Elacestrant

Published: July 26, 2026Updated: July 26, 2026

Orserdu is an oral selective estrogen receptor degrader (SERD) used to treat postmenopausal women and men with estrogen receptor-positive (ER+), HER2-negative advanced or metastatic breast cancer that has developed ESR1 mutations and progressed after at least one line of endocrine therapy. It works by binding to and degrading estrogen receptors, blocking the estrogen signals that fuel certain breast cancers.

Quick summary

Orserdu is a targeted oral therapy for ER+/HER2- breast cancer with ESR1 mutations that no longer responds to standard endocrine treatment.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

RxNorm
2628479
Generic
Orserdu
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Treatment of ER+/HER2- advanced or metastatic breast cancer in postmenopausal women and men with ESR1 mutations whose disease has progressed following at least one line of endocrine therapy. ESR1 mutations are detected through FDA-approved testing.

Orserdu is a selective estrogen receptor degrader (SERD). It selectively binds to estrogen receptors (ER) in cancer cells, inducing a conformational change that leads to receptor degradation. By reducing ER levels, it blocks estrogen-mediated signaling and inhibits tumor growth in ER-dependent cancers.

Common side effects include musculoskeletal pain, nausea, fatigue, vomiting, and hot flashes. Use with caution in patients with liver impairment. May cause fetal harm; effective contraception required during treatment. As a tablet taken once daily with or without food, adherence is important for optimal outcomes.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy